UnicoCell
Toggle navigation
About
Cell Therapy
Products & services
News
Contact
中文
/
EN
News
2024.05.21 UnicoCell Biomed (6794) was Publicly Listed on Taiwan Innovation Board
2024.05.14 UnicoCell has passed the onsite inspection of cell processing facility from Japan MHLW (Ministry of Health, Labor and Welfare)
2024.04.18 UnicoCell Biomed held a Pre-IPO Investor Conference on the TIB (Taiwan Innovation Board)
2024.02.17 The stem cell new drug, ELIXCYTE, honored by the international journal Cytotherapy acceptance
2023.11.28 UnicoCell, Taiwan Leading Company of Promising Allogeneic Stem Cell New Drug, applied to Taiwan Stock Exchange for IPO on Innovative Board
2023.11.09 The Ministry of Health and Welfare approved the application for the RASMET in cooperation with the PaoChien Hospital.
Products & services
Conditioned Medium
MORE
Mass Production and CDMO
MORE
Autologous Stem Cell Therapy
MORE
Allogeneic Adipose Stem Cell Bank
MORE